Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Neuroprotection: challenges and opportunities Faden AI; Stoica BArch Neurol 2007[Jun]; 64 (6): 794-800The ability of pharmacological agents to limit secondary biochemical damage and cell death has been well established in numerous animal models of stroke, head injury, and spinal cord injury, yet the results of such neuroprotective treatment strategies in human injury have been disappointing. A number of conceptual and methodological issues have undoubtedly contributed to the difficulties in translating the experimental results to the clinic. Most recently, different experimental approaches and altered clinical trial methodologies have provided renewed, albeit cautious, optimism regarding future clinical trials of neuroprotective agents. Herein, we reviewed both the critical problems and potential solutions, emphasizing recent experimental and clinical work.|Animals[MESH]|Clinical Trials as Topic[MESH]|Craniocerebral Trauma/*drug therapy[MESH]|Drug Evaluation, Preclinical[MESH]|Genomics[MESH]|Humans[MESH]|Neuroprotective Agents/*therapeutic use[MESH]|Proteomics[MESH]|Research[MESH]|Spinal Cord Injuries/*drug therapy[MESH]|Stroke/*drug therapy[MESH] |